glp-1 lasker 2024 Lasker-DeBakey Clinical Medical Research Award winner Svetlana Mojsov describes her discovery of glucagon-like peptide (GLP)-1, the biologically active incretin that led to development of effective analogues for diabetes and obesity Obesity-Drug Pioneers Win Prestigious Lasker
Description
Will Chinese food cause nausea or side effects on tirzepatide
Patients with F2F3 fibrosis may be candidates for FDA-approved resmetirom
By 2022, that had more than quadrupled to $2.21 PMPM
Karakasis et al
This is part of why fiber-rich diets are associated with better satiety and steadier energy
